After One-Off Cash Infusions, YZY Biopharma Looks for More Funds From IPO
The cash-challenged biotech firm specializing in BsAbs and immuno-oncology therapies is turning to a Hong Kong listing to try to replenish its coffersKey Takeaways:YZY Biopharma has filed for a Hong…